Four years after he resigned as…
Four years after he resigned as chief medical officer at [...]
Four years after he resigned as chief medical officer at [...]
As Candel Therapeutics gears up for a planned U.S. approval [...]
The Swiss drugmaker has plucked an experienced scientist from Down [...]
As recent changes to U.S. vaccine policy face pushback on [...]
Novartis has jettisoned an anti-cancer protein from its pipeline after [...]
Throughout 2025, the world’s first metabolic dysfunction-associated steatohepatitis (MASH) drug [...]
Politico has reported that the White House isn’t happy with [...]
In a fourth-quarter conference call, Insmed CEO Will Lewis admitted [...]
An untitled letter shared to the agency’s public database this [...]
Johnson & Johnson has paused further enrollment in a phase [...]